Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients.

Autor: Schumock GT, Andress D, Marx SE, Sterz R, Joyce AT, Kalantar-Zadeh K

Publikováno v: Current Medical Research & Opinion; Nov2008, Vol. 24 Issue 11, p3037-3048, 12p

PUK9 HEALTH ECONOMIC EVALUATION OF PARICALCITOL COMPARED TO NON-SELECTIVE VITAMIN D RECEPTOR ACTIVATOR FORTHETREATMENT OF SECONDARY HYPERPARATHYROIDISM IN CHRONIC KIDNEY DISEASE PATIENTS: US PERSPECTIVE

Autor: Nuijten, MJ, Marx, SE, Andress, D, Sterz, R

Publikováno v: In Value in Health 2008 11(3):A303-A303

PRP22: IS CISATRACURIUM COST EFFECTIVE FOR NEUROMUSCULAR BLOCKADE IN THE ICU? A MARKOV COMPUTER SIMULATION STUDY

Autor: Macario, A, Marx, SE, Chow, JL

Publikováno v: In Value in Health 2003 6(3):373-373

Shorter Duration Hepatitis C Virus Treatment is Associated with Better Persistence to Prescription Refills in People Who Inject Drugs: A Real-World Study.

Autor: Martinez A; Department of Medicine, University at Buffalo, State University of New York, 462 Grider Street, Buffalo, NY, 14215, USA. adm35@buffalo.edu., Cheng WH; AbbVie Inc., North Chicago, IL, USA., Marx SE; AbbVie Inc., North Chicago, IL, USA., Manthena S; AbbVie Inc., North Chicago, IL, USA., Dylla DE; AbbVie Inc., North Chicago, IL, USA., Wilson L; Genesis Research, Hoboken, NJ, USA., Thomas E; University of Miami Miller School of Medicine, Miami, FL, USA.

Publikováno v: Advances in therapy [Adv Ther] 2023 Aug; Vol. 40 (8), pp. 3465-3477. Date of Electronic Publication: 2023 Jun 07.